Results 141 to 150 of about 279,410 (290)
A soil food web approach to integrate soil fauna into multitrophic biogeochemistry. [PDF]
Lejoly JDM, Mason-Jones K, Veen GFC.
europepmc +1 more source
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Meddelanden af Societas pro Fauna et Flora Fennica
Haft.
Societas pro Fauna et Flora Fennica +1 more
core
Brachiopoda collection of the Shirshov Institute of Oceanology, Russian Academy of Sciences. [PDF]
Dudnik Z.
europepmc +1 more source
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
Meddelanden af Societas pro Fauna et Flora Fennica
Haft.
Societas pro Fauna et Flora Fennica +1 more
core
The European Upper Palaeolithic Palaeoecological and Archaeological Dataset for sites north of 50°N. [PDF]
Böckenförde T.
europepmc +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Study of the helminth fauna in booted eagle (<i>Hieraaetus pennatus</i>) in the South of Spain. [PDF]
Rufino-Moya PJ +9 more
europepmc +1 more source
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source

